Financial Instruments and Fair Value Measurements | 3 Months Ended |
Mar. 31, 2014 |
Derivative Instruments And Hedging Activities Disclosure [Abstract] | ' |
Financial Instruments and Fair Value Measurements | ' |
10 | Financial Instruments and Fair Value Measurements | | | | | | | | | | | | | | | | | | | | | | | |
Derivative Financial Instruments |
In the normal course of business, our operations are exposed to global market risks, including the effect of changes in foreign currency exchange rates and interest rates. To manage these risks, we may enter into various derivative contracts, such as foreign currency contracts to manage foreign currency exposure, and interest rate swaps to manage the effect of interest rate fluctuations. The majority of our derivative financial instruments are customized derivative transactions and are not exchange-traded. We only enter into transactions that we believe will be highly effective at offsetting the underlying risk. There have been no significant changes in our policy or strategy from what was previously disclosed in our Annual Report on Form 10-K for the fiscal year ended December, 31, 2013. |
Foreign Currency |
We hedge the net assets of certain international subsidiaries using foreign currency derivative contracts (net investment hedges) to offset the translation and economic exposures related to our investments in these subsidiaries by locking in a forward exchange rate at the inception of the hedge. We measure the effectiveness of our net investment hedges by using the changes in forward exchange rates because this method reflects our risk management strategies, the economics of those strategies in the financial statements and better manages interest rate differentials between different countries. Under this method, all changes in fair value of the forward currency derivative contracts designated as net investment hedges are reported in equity in the foreign currency translation component of Accumulated Other Comprehensive Income (Loss) in the Consolidated Balance Sheets (“AOCI”) and offsets translation adjustments on the underlying net assets of our foreign investments, which are also recorded in AOCI. Ineffectiveness, if any, is recognized in earnings. |
In certain circumstances, we may also borrow debt in a currency that is not the same functional currency of the borrowing entity to offset the translation and economic exposures related to our net investment in international subsidiaries. To mitigate the impact to our earnings from the fluctuations in the exchange rate, we may designate the debt as a non-derivative financial instrument hedge. We measure our effectiveness in the same manner as our net investment hedges described above. As a result, the change in the value of this debt upon translation is recorded in the foreign currency translation component of AOCI to offset the foreign currency fluctuations related to the net investment in our subsidiaries with the same functional currency as the debt. |
Interest Rate |
Our interest rate risk management strategy is to limit the impact of future interest rate changes on earnings and cash flows as well as to stabilize interest expense and manage our exposure to interest rate movements. We may enter into interest rate swap agreements that allow us to receive variable-rate amounts from a counterparty in exchange for us making fixed-rate payments over the life of the agreement. The effective portion of the gain or loss on the derivative is reported as a component of AOCI in the Consolidated Balance Sheets, and reclassified to Interest Expense in the Consolidated Statements of Operations over the corresponding period of the hedged item. Losses on a derivative representing hedge ineffectiveness, if any, are recognized in Interest Expense at the time the ineffectiveness occurred. |
Summary of Activity |
The following table summarizes the activity in our derivative instruments for the three months ended March 31, (in millions): |
|
| | | | | | | | | | | | | | | | | | | | | | | | |
| | 2014 | | | 2013 | | | | | | | | | |
| | Foreign | | | Interest Rate | | | Foreign | | | Interest Rate | | | | | | | | | |
Currency | Swaps (2) | Currency | Swaps (3) | | | | | | | | |
Contracts (1) | | Forwards | | | | | | | | | |
Notional amounts at January 1, | | $ | 1,050.00 | | | $ | 71 | | | $ | 1,303.80 | | | $ | 1,314.80 | | | | | | | | | |
New contracts | | | 1,040.00 | | | | — | | | | — | | | | — | | | | | | | | | |
Matured or expired contracts | | | (470.0 | ) | | | — | | | | (663.7 | ) | | | (1,230.2 | ) | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | |
Notional amounts at March 31, | | $ | 1,620.00 | | | $ | 71 | | | $ | 640.1 | | | $ | 84.6 | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | |
|
-1 | To hedge a portion of our investment in Europe at a fixed euro rate in U.S. dollars, we entered into two foreign currency contracts that expired in March with an aggregate notional amount of €345.9 million ($470.0 million using the weighted average forward rate of 1.36) and four foreign currency contracts that will expire in April 2014 with an aggregate notional amount of €414.5 million ($570.0 million using the weighted average forward rate of 1.38). As of March 31, 2014, we had 11 contracts with an aggregate notional amount of €1.0 billion ($1.4 billion using the weighted average forward rate of 1.35) and three contracts with an aggregate notional amount of ¥24.1billion ($250.0 million using the weighted average forward rate of 96.54). | | | | | | | | | | | | | | | | | | | | | | | |
-2 | We currently have one interest rate swap contract that matures in May 2017. | | | | | | | | | | | | | | | | | | | | | | | |
-3 | During the three months ended March 31, 2013, we settled or contributed contracts in connection with the formation of our new co-investment ventures in Europe and Japan. | | | | | | | | | | | | | | | | | | | | | | | |
|
As discussed in Note 6, we issued €700 million ($959.4 million) of debt in February 2014. This debt was issued by the Operating Partnership, which is a U.S. dollar functional entity, and designated as a non-derivative financial instrument hedge. As of March 31, 2014 and December 31, 2013, we had €1.4 billion ($1.9 billion) and €700 million ($1.0 billion) of debt designated as non-derivative financial instrument hedges on our net investment in international subsidiaries, respectively. Amounts included in AOCI in the Consolidated Balance Sheets at March 31, 2014 and December 31, 2013, were losses of $20.4 million and $14.9 million, respectively. |
All derivatives are recognized at fair value in the Consolidated Balance Sheets and are within the line items Other Assets or Accounts Payable and Accrued Expenses, as applicable. Changes in the fair value of derivatives that are designated and qualify as cash flow hedges and hedges of net investments in foreign operations are recorded as accumulated gains (losses) in AOCI in the Consolidated Balance Sheets. The following table presents the fair value of our derivative instruments (in thousands): |
|
| | | | | | | | | | | | | | | | | | | | | | | | |
| | March 31, 2014 | | | December 31, 2013 | |
| | Asset | | | Liability | | | AOCI | | | Asset | | | Liability | | | AOCI | |
Net investment hedges—euro denominated | | $ | 407 | | | $ | 38,042 | | | $ | (35,334 | ) | | $ | 137 | | | $ | 30,302 | | | $ | (21,705 | ) |
Net investment hedges—yen denominated | | | 15,786 | | | | — | | | | 18,817 | | | | 20,104 | | | | — | | | | 22,102 | |
Interest rate swap hedges | | | — | | | | 5,264 | | | | (15,549 | ) | | | — | | | | 5,638 | | | | (14,442 | ) |
| | | | | | | | | | | | | | | | | | | | | | | | |
Total derivatives | | $ | 16,193 | | | $ | 43,306 | | | $ | (32,066 | ) | | $ | 20,241 | | | $ | 35,940 | | | $ | (14,045 | ) |
| | | | | | | | | | | | | | | | | | | | | | | | |
During the three months ended March 31, 2014, we did not record any ineffectiveness on our derivative contracts. During the three months ended March 31, 2013, we had no significant hedge ineffectiveness. In addition, the effective portion of the gain or loss on the interest rate swaps reclassified to interest expense was not considered significant for the first quarter of 2014, and is not expected to be significant for the next 12 months. In the first quarter 2013, the effective portion reclassified to interest expense was $2.3 million. |
The following table presents gains (losses) from the change in fair value for the effective portion of our derivative and non-derivative instruments included in Other Comprehensive Income (Loss) in the Consolidated Statements of Comprehensive Income (Loss) for the three months ended March 31, (in thousands): |
|
| | | | | | | | | | | | | | | | | | | | | | | | |
| | 2014 | | | 2013 | | | | | | | | | | | | | | | | | |
Derivative net investment hedges (1) | | $ | (16,914 | ) | | $ | 34,724 | | | | | | | | | | | | | | | | | |
Non-derivative net investment hedges | | | (5,530 | ) | | | — | | | | | | | | | | | | | | | | | |
Interest rate swap hedges | | | (1,107 | ) | | | 12,511 | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | |
Total derivatives | | $ | (23,551 | ) | | $ | 47,235 | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | |
|
-1 | This includes losses of $6.9 million and gains of $5.4 million in 2014 and 2013, respectively, upon the settlement of net investment hedges. | | | | | | | | | | | | | | | | | | | | | | | |
Fair Value Measurements |
We have estimated the fair value of our financial instruments using available market information and valuation methodologies we believe to be appropriate for these purposes. Considerable judgment and a high degree of subjectivity are involved in developing these estimates and, accordingly, they are not necessarily indicative of amounts that we would realize upon disposition. |
Fair Value Measurements on a Recurring Basis |
At March 31, 2014 and December 31, 2013, other than the derivatives discussed above and in Note 6, we do not have any significant financial assets or financial liabilities that are measured at fair value on a recurring basis in the Consolidated Financial Statements. The fair value of our derivative instruments were determined using widely accepted valuation techniques including discounted cash flow analysis on the expected cash flows of each derivative. This analysis reflects the contractual terms of the derivatives, including the period to maturity, and uses observable market-based inputs, including interest rate curves, foreign exchange rates, and implied volatilities. The fair values of our interest rate swaps are determined using the market standard methodology of netting the discounted future fixed cash receipts or payments and the discounted expected variable cash payments. The variable cash payments are based on an expectation of future interest rates, or forward curves, derived from observable market interest rate curves. The fair values of our net investment hedges are based upon the change in the spot rate at the end of the period as compared to the strike price at inception. |
We incorporate credit valuation adjustments to appropriately reflect both our nonperformance risk and the respective counterparty’s nonperformance risk in the fair value measurements. In adjusting the fair value of our derivative contracts for the effect of nonperformance risk, we have considered the impact of netting and any applicable credit enhancements, such as collateral postings, thresholds, mutual puts, and guarantees. |
We have determined that the majority of the inputs used to value our derivatives fall within Level 2 of the fair value hierarchy. Although the credit valuation adjustments associated with our derivatives utilize Level 3 inputs, such as estimates of current credit spreads to evaluate the likelihood of default by us and our counterparties, we assessed the significance of the impact of the credit valuation adjustments on the overall valuation of our derivative positions and have determined that the credit valuation adjustments are not significant to the overall valuation of our derivatives. As a result, all of our derivatives held as of March 31, 2014 and December 31, 2013, were classified as Level 2 of the fair value hierarchy. |
|
Fair Value Measurements on Non-Recurring Basis |
Assets measured at fair value on a non-recurring basis in the Consolidated Financial Statements consist of real estate assets and investments in and advances to unconsolidated entities that were subject to impairment charges. There were no assets that met these criteria at March 31, 2014 and December 31, 2013. |
Fair Value of Financial Instruments |
At March 31, 2014 and December 31, 2013, our carrying amounts of certain financial instruments, including cash and cash equivalents, restricted cash, accounts and notes receivable, accounts payable and accrued expenses were representative of their fair values due to the short-term nature of these instruments. |
At March 31, 2014 and December 31, 2013, the fair value of our senior notes and exchangeable senior notes has been estimated based upon quoted market prices for the same (Level 1) or similar (Level 2) issues when current quoted market prices are available, the fair value of our Credit Facilities has been estimated by discounting the future cash flows using rates and borrowing spreads currently available to us (Level 3), and the fair value of our secured mortgage debt and assessment bonds that do not have current quoted market prices available has been estimated by discounting the future cash flows using rates currently available to us for debt with similar terms and maturities (Level 3). The differences in the fair value of our debt from the carrying value in the table below are the result of differences in interest rates and/or borrowing spreads that were available to us at March 31, 2014 and December 31, 2013, as compared with those in effect when the debt was issued or acquired. The senior notes and many of the issues of secured mortgage debt contain pre-payment penalties or yield maintenance provisions that could make the cost of refinancing the debt at lower rates exceed the benefit that would be derived from doing so. |
The following table reflects the carrying amounts and estimated fair values of our debt (in thousands): |
|
| | | | | | | | | | | | | | | | | | | | | | | | |
| | March 31, 2014 | | | December 31, 2013 | | | | | | | | | |
| | Carrying Value | | | Fair Value | | | Carrying Value | | | Fair Value | | | | | | | | | |
Credit Facilities | | $ | 119,466 | | | $ | 119,711 | | | $ | 725,483 | | | $ | 725,679 | | | | | | | | | |
Senior notes | | | 6,296,308 | | | | 6,676,298 | | | | 5,357,933 | | | | 5,698,864 | | | | | | | | | |
Exchangeable senior notes | | | 442,729 | | | | 532,783 | | | | 438,481 | | | | 514,381 | | | | | | | | | |
Secured mortgage debt | | | 1,674,488 | | | | 1,825,836 | | | | 1,696,597 | | | | 1,840,829 | | | | | | | | | |
Secured mortgage debt of consolidated entities | | | 238,148 | | | | 248,154 | | | | 239,992 | | | | 246,324 | | | | | | | | | |
Term loan and other debt | | | 99,496 | | | | 101,437 | | | | 552,730 | | | | 560,714 | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | |
Total debt | | $ | 8,870,635 | | | $ | 9,504,219 | | | $ | 9,011,216 | | | $ | 9,586,791 | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | |
|